From the reviews: "Based on the proceedings of a Falk Symposium cosponsored by the American Gastroenterological Association and held in China in March 2008, this book reports on recent progress in chronic inflammatory diseases of the liver and gut. ... it is predominantly a record of the various presentations and aimed at gastroenterologists and hepatologists interested in chronic inflammation of the gut and liver ... ." (Willem J. S. de Villiers, Doody's Review Service, December, 2009)

• Inflammatory bowel disease.- State-of-the-Art Lecture: Pathogenesis of inflammatory bowel disease: converging paradigms.- The role of the epithelium in inflammatory bowel disease.- Implications of genetics for clinical practice.- Epidemiology of inflammatory bowel disease in China.- State-of-the-Art Lecture: The enteric microbiota: implications in inflammatory bowel disease.- Can we predict the natural history of ulcerative colitis?.- Inflammatory bowel disease.- Practical use of steroids in inflammatory bowel disease.- Prevention of cancer in inflammatory bowel disease and the potential chemopreventive effect of aminosalicylates.- Therapy of inflammatory bowel disease: bottom-up or top-down?.- State-of-the-Art Lecture: The future of biologic therapy in Asia.- Chronic liver disease.- State-of-the-Art Lecture: The liver as an immune organ.- Treatment strategies for hepatitis B in the West.- Treatment strategies of hepatitis B in China.- State-of-the-Art Lecture: Treatment of hepatitis C.- State-of-the-Art Lecture: Non-alcoholic steatohepatitis: concepts on pathogenesis and therapy.- Liver fibrogenesis: how to stop progression?.- Clinical aspects of primary biliary cirrhosis.- Chronic liver disease.- Pathophysiology of portal hypertension and variceal bleeding.- Management of ascites and hepatorenal syndrome.- Antiviral therapy for hepatitis B virus-associated hepatic failure.- Adult-to-adult living donor liver transplantation — triumphs and challenges.- Chronic infection of hepatitis B virus and hepatocellular carcinoma in China.

From the reviews: "Based on the proceedings of a Falk Symposium cosponsored by the American Gastroenterological Association and held in China in March 2008, this book reports on recent progress in chronic inflammatory diseases of the liver and gut. ... it is predominantly a record of the various presentations and aimed at gastroenterologists and hepatologists interested in chronic inflammation of the gut and liver ... ." (Willem J. S. de Villiers, Doody's Review Service, December, 2009)

• Inflammatory bowel disease.- State-of-the-Art Lecture: Pathogenesis of inflammatory bowel disease: converging paradigms.- The role of the epithelium in inflammatory bowel disease.- Implications of genetics for clinical practice.- Epidemiology of inflammatory bowel disease in China.- State-of-the-Art Lecture: The enteric microbiota: implications in inflammatory bowel disease.- Can we predict the natural history of ulcerative colitis?.- Inflammatory bowel disease.- Practical use of steroids in inflammatory bowel disease.- Prevention of cancer in inflammatory bowel disease and the potential chemopreventive effect of aminosalicylates.- Therapy of inflammatory bowel disease: bottom-up or top-down?.- State-of-the-Art Lecture: The future of biologic therapy in Asia.- Chronic liver disease.- State-of-the-Art Lecture: The liver as an immune organ.- Treatment strategies for hepatitis B in the West.- Treatment strategies of hepatitis B in China.- State-of-the-Art Lecture: Treatment of hepatitis C.- State-of-the-Art Lecture: Non-alcoholic steatohepatitis: concepts on pathogenesis and therapy.- Liver fibrogenesis: how to stop progression?.- Clinical aspects of primary biliary cirrhosis.- Chronic liver disease.- Pathophysiology of portal hypertension and variceal bleeding.- Management of ascites and hepatorenal syndrome.- Antiviral therapy for hepatitis B virus-associated hepatic failure.- Adult-to-adult living donor liver transplantation — triumphs and challenges.- Chronic infection of hepatitis B virus and hepatocellular carcinoma in China.

From the reviews: "Based on the proceedings of a Falk Symposium cosponsored by the American Gastroenterological Association and held in China in March 2008, this book reports on recent progress in chronic inflammatory diseases of the liver and gut. ... it is predominantly a record of the various presentations and aimed at gastroenterologists and hepatologists interested in chronic inflammation of the gut and liver ... ." (Willem J. S. de Villiers, Doody's Review Service, December, 2009)

• Inflammatory bowel disease.- State-of-the-Art Lecture: Pathogenesis of inflammatory bowel disease: converging paradigms.- The role of the epithelium in inflammatory bowel disease.- Implications of genetics for clinical practice.- Epidemiology of inflammatory bowel disease in China.- State-of-the-Art Lecture: The enteric microbiota: implications in inflammatory bowel disease.- Can we predict the natural history of ulcerative colitis?.- Inflammatory bowel disease.- Practical use of steroids in inflammatory bowel disease.- Prevention of cancer in inflammatory bowel disease and the potential chemopreventive effect of aminosalicylates.- Therapy of inflammatory bowel disease: bottom-up or top-down?.- State-of-the-Art Lecture: The future of biologic therapy in Asia.- Chronic liver disease.- State-of-the-Art Lecture: The liver as an immune organ.- Treatment strategies for hepatitis B in the West.- Treatment strategies of hepatitis B in China.- State-of-the-Art Lecture: Treatment of hepatitis C.- State-of-the-Art Lecture: Non-alcoholic steatohepatitis: concepts on pathogenesis and therapy.- Liver fibrogenesis: how to stop progression?.- Clinical aspects of primary biliary cirrhosis.- Chronic liver disease.- Pathophysiology of portal hypertension and variceal bleeding.- Management of ascites and hepatorenal syndrome.- Antiviral therapy for hepatitis B virus-associated hepatic failure.- Adult-to-adult living donor liver transplantation — triumphs and challenges.- Chronic infection of hepatitis B virus and hepatocellular carcinoma in China.